Skip to main content
Apeloa Pharmaceutical Co.,Ltd. logo

Apeloa Pharmaceutical Co.,Ltd. — Investor Relations & Filings

Ticker · 000739 ISIN · CNE000000Q45 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,841 across all filing types
Latest filing 2023-03-31 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 000739

About Apeloa Pharmaceutical Co.,Ltd.

https://www.apeloa.com

Apeloa Pharmaceutical Co., Ltd. focuses on the research, development, manufacturing, and distribution of active pharmaceutical ingredients (APIs), intermediates, and finished dosage forms. The company operates three core business pillars: API production, Contract Development and Manufacturing Organization (CDMO) services, and finished drug products. Its therapeutic focus includes cardiovascular, anti-infective, anti-viral, and oncology treatments. Apeloa utilizes an integrated supply chain to deliver chemical and biological solutions to a global client base. The organization maintains compliance with international quality standards, including certifications from the FDA, EMA, and PMDA. Its CDMO services encompass the full product lifecycle, from process chemistry and analytical development to large-scale commercial manufacturing, supported by specialized technology platforms such as continuous flow chemistry and enzymatic synthesis.

Recent filings

Filing Released Lang Actions
关于对下属公司担保的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from 普洛药业股份有限公司 regarding the progress of guarantees provided to its subsidiaries. It details the amounts, contracts, and financial status of the subsidiaries involved. The document is a formal disclosure about the company's guarantee activities, including board approval and risk assessment. It does not contain financial statements or comprehensive financial performance data, nor is it a report or presentation. It is a regulatory announcement about financing guarantees, which fits best under the category of Capital/Financing Update (CAP). The document length is 4176 characters, which is sufficient for a detailed announcement but not a full financial report. Therefore, the classification is CAP with high confidence.
2023-03-31 Chinese
第八届董事会第十八次会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the company's board of directors regarding the approval of an investment proposal and related party transaction. It includes details about the meeting date, attendance, voting results, and references a related announcement. The content focuses on board decisions and management actions rather than financial results, audit, or regulatory filings. It is not a full report, earnings release, or regulatory filing but a board/management information announcement about corporate governance and decisions. Therefore, the appropriate classification is Board/Management Information (MANG). The document length and content support this classification with high confidence.
2023-03-27 Chinese
关于投资设立产业基金暨关联交易的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by 普洛药业股份有限公司 regarding the investment to establish an industrial fund and related party transactions. It details the investment agreement, approval procedures, related party information, fund management, pricing policy, purpose and impact, independent directors' opinions, and risk warnings. The document is a formal disclosure of a capital investment and related party transaction, not a financial report, earnings release, or management discussion. It does not contain financial statements or quarterly/yearly results but focuses on a financing and investment update. The document length is 3631 characters, which is relatively short and typical for an announcement. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2023-03-27 Chinese
关于举行2022年年度报告网上业绩说明会的公告
Investor Presentation Classification · 95% confidence The document is an announcement about holding an online performance explanation meeting (业绩说明会) related to the 2022 annual report. It states the meeting date, participation details, and that the company has already disclosed the 2022 annual report on March 10, 2023. The document does not contain the annual report itself or detailed financial data, but rather invites investors to a presentation and Q&A session about the annual results. The document length is short (1093 characters) and it is clearly an announcement of a meeting related to the annual report, not the report itself. Therefore, it fits the category of Investor Presentation (IP) as it is a detailed presentation event for investors focusing on financials and company performance.
2023-03-22 Chinese
2023年第一季度业绩预告
Earnings Release Classification · 95% confidence The document is a quarterly earnings forecast for the first quarter of 2023, providing estimated net profit and earnings per share figures, along with explanations and risk warnings. It explicitly states that the financial data is preliminary and unaudited, and that detailed financial data will be disclosed in the official quarterly report later. This type of document is an initial announcement of quarterly financial results, which fits the definition of an Earnings Release (ER). The document length is short and it contains financial estimates rather than full financial statements, confirming it is not a full Interim/Quarterly Report (IR). Q1 2023
2023-03-22 Chinese
独立董事候选人声明（潘伟光）
Board/Management Information Classification · 95% confidence The document is a formal declaration by an independent director candidate of a company, confirming compliance with various legal and regulatory requirements for serving as an independent director. It includes detailed statements about qualifications, independence, and adherence to relevant laws and regulations. There is no financial data, no discussion of company performance, no voting results, no meeting materials, and no mention of report publication or regulatory filings. The content is focused on board/management information, specifically about the appointment and qualifications of a board member. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length (6062 characters) and detailed content support this classification with high confidence.
2023-03-09 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.